IM Cannabis Corp. (IMCC) Form 6-K — Nov 20, 2026
IM Cannabis Corp. (NASDAQ: IMCC) announced on November 20, 2026 that Ronen Zalayet was appointed Chief Executive Officer, effective November 19, succeeding founding CEO Oren Shuster, who resigned that role and his board seat. The company said the appointment aligns with its objective of building technology-driven businesses beyond its core medical cannabis operations. Alongside the CEO change, Shakked Shuster was named CEO of the company's Israeli subsidiary Focus Medical Herbs Ltd., and Ohad Melnik joined the board as an independent director, filling the vacancy left by Einat Zakariya's September 2026 resignation.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.